» Articles » PMID: 11306633

Intrathecal HIV-1 Envelope Glycoprotein Gp120 Induces Enhanced Pain States Mediated by Spinal Cord Proinflammatory Cytokines

Overview
Journal J Neurosci
Specialty Neurology
Date 2001 Apr 18
PMID 11306633
Citations 130
Authors
Affiliations
Soon will be listed here.
Abstract

Perispinal (intrathecal) injection of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein gp120 creates exaggerated pain states. Decreases in response thresholds to both heat stimuli (thermal hyperalgesia) and light tactile stimuli (mechanical allodynia) are rapidly induced after gp120 administration. gp120 is the portion of HIV-1 that binds to and activates microglia and astrocytes. These glial cells have been proposed to be key mediators of gp120-induced hyperalgesia and allodynia because these pain changes are blocked by drugs thought to affect glial function preferentially. The aim of the present series of studies was to determine whether gp120-induced pain changes involve proinflammatory cytokines [interleukin-1beta (IL-1) and tumor necrosis factor-alpha (TNF-alpha)], substances released from activated glia. IL-1 and TNF antagonists each prevented gp120-induced pain changes. Intrathecal gp120 produced time-dependent, site-specific increases in TNF and IL-1 protein release into lumbosacral CSF; parallel cytokine increases in lumbar dorsal spinal cord were also observed. Intrathecal administration of fluorocitrate (a glial metabolic inhibitor), TNF antagonist, and IL-1 antagonist each blocked gp120-induced increases in spinal IL-1 protein. These results support the concept that activated glia in dorsal spinal cord can create exaggerated pain states via the release of proinflammatory cytokines.

Citing Articles

Mitochondrial DNA and Electron Transport Chain Protein Levels Are Altered in Peripheral Nerve Tissues from Donors with HIV Sensory Neuropathy: A Pilot Study.

Boustani A, Kulbe J, Andalibi M, Perez-Santiago J, Mehta S, Ellis R Int J Mol Sci. 2024; 25(9).

PMID: 38731951 PMC: 11083172. DOI: 10.3390/ijms25094732.


Voluntary wheel running prevents formation of membrane attack complexes and myelin degradation after peripheral nerve injury.

Green-Fulgham S, Lacagnina M, Willcox K, Li J, Harland M, Ciena A Brain Behav Immun. 2023; 115:419-431.

PMID: 37924957 PMC: 10842182. DOI: 10.1016/j.bbi.2023.10.027.


Pathogenic mechanisms of human immunodeficiency virus (HIV)-associated pain.

Liu X, Tang S Mol Psychiatry. 2023; 28(9):3613-3624.

PMID: 37857809 DOI: 10.1038/s41380-023-02294-7.


Interleukin-1beta and inflammasome expression in spinal cord following chronic constriction injury in male and female rats.

Green-Fulgham S, Ball J, Kwilasz A, Harland M, Frank M, Dragavon J Brain Behav Immun. 2023; 115:157-168.

PMID: 37838078 PMC: 10841465. DOI: 10.1016/j.bbi.2023.10.004.


Progress in Pathological and Therapeutic Research of HIV-Related Neuropathic Pain.

Hu Y, Liu J, Zhuang R, Zhang C, Lin F, Wang J Cell Mol Neurobiol. 2023; 43(7):3343-3373.

PMID: 37470889 PMC: 11410024. DOI: 10.1007/s10571-023-01389-7.


References
1.
Shibuta S, Mashimoto T, OHara A, Zhang P, Yoshiya I . Intracerebroventricular administration of a nitric oxide-releasing compound, NOC-18, produces thermal hyperalgesia in rats. Neurosci Lett. 1995; 187(2):103-6. DOI: 10.1016/0304-3940(95)11354-1. View

2.
Tyor W, Glass J, Griffin J, Becker P, McArthur J, Bezman L . Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol. 1992; 31(4):349-60. DOI: 10.1002/ana.410310402. View

3.
Cunningham Jr E, DE SOUZA E . Interleukin 1 receptors in the brain and endocrine tissues. Immunol Today. 1993; 14(4):171-6. DOI: 10.1016/0167-5699(93)90281-o. View

4.
Coyle D . Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior. Glia. 1998; 23(1):75-83. View

5.
Corasaniti M, Melino G, Navarra M, Garaci E, Finazzi-Agro A, Nistico G . Death of cultured human neuroblastoma cells induced by HIV-1 gp120 is prevented by NMDA receptor antagonists and inhibitors of nitric oxide and cyclooxygenase. Neurodegeneration. 1995; 4(3):315-21. DOI: 10.1016/1055-8330(95)90021-7. View